These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 7705552

  • 1. Does sucralfate prevent short-term NSAID induced damage to the gastroduodenal mucosa?
    Gudjónsson H, Oddsson E, Thjodleifsson B.
    Digestion; 1994; 55(6):395-8. PubMed ID: 7705552
    [Abstract] [Full Text] [Related]

  • 2. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.
    Caldwell JR, Roth SH, Wu WC, Semble EL, Castell DO, Heller MD, Marsh WH.
    Am J Med; 1987 Sep 28; 83(3B):74-82. PubMed ID: 3310631
    [Abstract] [Full Text] [Related]

  • 3. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM, Saggioro A.
    J Rheumatol Suppl; 1991 Mar 28; 28():15-8. PubMed ID: 1674754
    [Abstract] [Full Text] [Related]

  • 4. Sucralfate for prevention of naproxen-induced mucosal lesions in the proximal and distal gastrointestinal tract.
    Aabakken L, Larsen S, Osnes M.
    Scand J Rheumatol; 1989 Mar 28; 18(6):361-8. PubMed ID: 2515593
    [Abstract] [Full Text] [Related]

  • 5. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
    Miglioli M, Bianchi Porro G, Vaira D, Menegatti M, Brunetti G, Petrillo M, Ardizzone S, Frizziero L, Montrone F, Grandinetti G.
    Am J Gastroenterol; 1996 Nov 28; 91(11):2367-71. PubMed ID: 8931419
    [Abstract] [Full Text] [Related]

  • 6. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ, Agrawal NM.
    Dig Dis; 1995 Jan 28; 13 Suppl 1():48-61. PubMed ID: 7697902
    [Abstract] [Full Text] [Related]

  • 7. The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study.
    Lazzaroni M, Anderloni A, Bianchi Porro G.
    Eur J Gastroenterol Hepatol; 2001 Jul 28; 13(7):833-9. PubMed ID: 11474314
    [Abstract] [Full Text] [Related]

  • 8. Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury. Effect of scoring method.
    Lanza FL, Graham DY, Davis RE, Rack MF.
    Dig Dis Sci; 1990 Dec 28; 35(12):1494-9. PubMed ID: 2253535
    [Abstract] [Full Text] [Related]

  • 9. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
    Lanza FL, Codispoti JR, Nelson EB.
    Am J Gastroenterol; 1998 Jul 28; 93(7):1051-4. PubMed ID: 9672328
    [Abstract] [Full Text] [Related]

  • 10. Sucralfate therapy in NSAID bleeding gastropathy.
    Malagelada JR, Rodríguez de la Serna A, Dammann HG, Pons M, Armas C, Sala M, Tena X, Celdrán E, Mesa A.
    Clin Gastroenterol Hepatol; 2003 Jan 28; 1(1):51-6. PubMed ID: 15017517
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G, Lazzaroni M, Petrillo M.
    Am J Gastroenterol; 1997 Apr 28; 92(4):663-7. PubMed ID: 9128319
    [Abstract] [Full Text] [Related]

  • 12. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen.
    Oddsson E, Gudjónsson H, Thjódleifsson B.
    Scand J Gastroenterol; 1992 Dec 28; 27(12):1045-8. PubMed ID: 1475621
    [Abstract] [Full Text] [Related]

  • 13. Injurious effect of Helicobacter pylori culture fluid to gastroduodenal mucosa, and its detoxification by sucralfate in the rat.
    Watanabe K, Joh T, Seno K, Takahashi N, Ohara H, Nomura T, Tochikubo K, Itoh M.
    Aliment Pharmacol Ther; 1999 Oct 28; 13(10):1363-71. PubMed ID: 10540053
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study.
    Miller K.
    Hepatogastroenterology; 1997 Oct 28; 44(15):872-9. PubMed ID: 9222707
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate.
    Stiel D, Ellard KT, Hills LJ, Brooks PM.
    Am J Med; 1986 Aug 18; 81(2A):54-8. PubMed ID: 3092656
    [Abstract] [Full Text] [Related]

  • 18. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
    Lazzaroni M, Sainaghi M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Aug 18; 31 Suppl 1():S48-53. PubMed ID: 10379470
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen.
    Bjarnason I, Macpherson A, Rotman H, Schupp J, Hayllar J.
    Scand J Gastroenterol; 1997 Feb 18; 32(2):126-30. PubMed ID: 9051872
    [Abstract] [Full Text] [Related]

  • 20. Effects of alendronate on gastric and duodenal mucosa.
    Lanza F, Rack MF, Simon TJ, Lombardi A, Reyes R, Suryawanshi S.
    Am J Gastroenterol; 1998 May 18; 93(5):753-7. PubMed ID: 9625122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.